P. Zück

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

R. Finch, Dirk Schürmann, Owen Collins et al. · Antimicrobial Agents and Chemotherapy · 2002 · 184 citations · Full text

Community-acquired Pneumonia, Oral Moxifloxacin Compared, Oral Co-amoxiclav +12

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

H. Portier, Christian Brambilla, M Garré et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2005 · 48 citations

Antibiotics, Moxifloxacin Monotherapy, Clinical Epidemiology +8

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis

P Periti, Andrea Novelli, G Schildwächter et al. · Journal of Antimicrobial Chemotherapy · 1990 · 45 citations

Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia

P. Zück, Y. Rio, F. Ichou · Journal of Antimicrobial Chemotherapy · 1990 · 45 citations

Pulmonary Care, Antibiotics, Cefpodoxime Proxetil 200 +12

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

C. E. Langan, P. Zück, F. Vogel et al. · Journal of Antimicrobial Chemotherapy · 1999 · 42 citations · Full text